GM1 ganglioside Review

The potential that GM1 gangliosdie holds for neurological disesase continues with no FDA approved source. Patients with diseases including Huntington's. Parkinson's, Alzheimer's, peripheral neuropathy, glioblastoma, cystic fibrosis, diabetes, spinal cord injury, traumatic brain injury can benefit. The role GM1 plays in our bodies is extensive and patients with a lack of GM1 can benefit from a replacement treatment. The possible applications for GM1 as a therapeutic across diseases cannot be understated, and no other product sold or manufactured is equal to the potential benefits of ovine GM1. Far too many projects, clinical trials, and people suffering from diseases have had progress robbed from them, simply because of lack of GM1 supply and traceability. We continue to work with GM1 while seeking assistance to move into clinical trials. This video reviews decades of work.